Can We Keep the 'PROMISE'? AGO Breast Commission: Commentary on Recent Evidence Regarding LHRH Analogues for the Preservation of Ovarian Function.

about

Can We Keep the 'PROMISE'? AGO Breast Commission: Commentary on Recent Evidence Regarding LHRH Analogues for the Preservation of Ovarian Function.

Item

http://www.wikidata.org/entity/Q35789448

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Can We Keep the 'PROMISE'? AGO ...... servation of Ovarian Function.

@ast

Can We Keep the 'PROMISE'? AGO ...... servation of Ovarian Function.

@en

type

Item

label

Can We Keep the 'PROMISE'? AGO ...... servation of Ovarian Function.

@ast

Can We Keep the 'PROMISE'? AGO ...... servation of Ovarian Function.

@en

prefLabel

Can We Keep the 'PROMISE'? AGO ...... servation of Ovarian Function.

@ast

Can We Keep the 'PROMISE'? AGO ...... servation of Ovarian Function.

@en

P1476

Can We Keep the 'PROMISE'? AGO ...... servation of Ovarian Function.

@en

P2093

Nicos Fersis

http://www.w3.org/2001/XMLSchema#string

P2860

Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial.

Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: a systematic review.

Use of hormonal protection for chemotherapy-induced gonadotoxicity.

Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis.

Gonadal toxicity following cancer therapy in adults: significance, diagnosis, prevention and treatment.

Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.

Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer.

Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial.

P304

467-470

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000335477

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sibylle Loibl

Nadia Harbeck

P577

2011-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221703999

http://www.w3.org/2001/XMLSchema#string

P698

22419902

http://www.w3.org/2001/XMLSchema#string

P932

3290029

http://www.w3.org/2001/XMLSchema#string